Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference Call
Quotient Limited (NASDAQ: QTNT) will release its fiscal third-quarter financial results for the period ending December 31, 2021, on February 8, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Quotient Limited (NASDAQ: QTNT) will release its fiscal third-quarter financial results for the period ending December 31, 2021, on February 8, 2022. A conference call to discuss these results will take place at 8:00 am Eastern Time, with dial-in numbers provided for US and international participants. Quotient aims to reshape diagnostics with its MosaiQ technology, a fully automated testing platform intended to enhance efficiency and reduce operational costs in laboratories globally. The replay of the conference call will be available until February 15, 2022.
Positive
- MosaiQ technology designed to improve efficiency in laboratories.
- Commitment to innovative diagnostic solutions.
Negative
- None.
Details
News Market Reaction – QTNT
The recorded move for QTNT in the trading session of this news was -3.70%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
JERSEY, Channel Islands, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2021 will be released before market open on Tuesday, February 8, 2022.
Quotient will host a conference call to discuss its third quarter financial results at 8:00am Eastern Time the same day. Participants may access the conference call by dialing 1-877-407-0784 (US) or 1-201-689-8560 (International), using conference ID 13725727. The conference call will be webcast live on the Company's website at www.quotientbd.com.
A replay of the conference call will be available through February 15, 2022 by dialing 1-844-512-2921 in the US or 1-412-317-6671 if international. The replay access code is 13725727.
About Quotient Limited
Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and create operational cost savings to laboratories around the world. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania. The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.
CONTACT: Investor Relations, ir@quotientbd.com; +41 22 545 52 26
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.